Health & Safety Industry Today

Improvement in diagnosis is Driving the Global Cancer Biomarker Market at a CAGR of 11.32% by 2027

According to a new market research report launched by Inkwood Research, The Global Cancer Biomarker Market was valued at nearly $12,132 million in 2018 and is anticipated to reach around $31,641 million by 2027, growing at an estimated CAGR of 11.32%, during the forecast period 2019-2027.
Published 14 August 2019
Browse 32 market data Tables and 16 Figures spread over 50+ Pages along with in-depth analysis on Global Cancer Biomarker Market by By Profiling (Omics technology (Genomics (Next-generation sequencing (NGS), Microarray, Polymerase chain reaction (PCR)), Proteomics (Mass spectrometry, 2D gel electrophoresis, Protein microarray technology, Antibody array technology, Peptide array technology), Other Omic technologies (Metabolomics, Glycomics), Imaging technologies (Magnetic resonance imaging (MRI), Positron emission tomography (PET), Computed tomography, Mammography, Ultrasound), Immunoassays (Immunohistochemistry (IHC) tests, Enzyme-linked immunosorbent assay (ELISA), Flow cytometry), Cytogenetic-based tests (In situ hybridization, Others cytogenetic-based tests))), By Biomarker (Genetic biomarkers, Protein biomarkers, Glyco biomarkers), By Cancer type (Lung cancer, Breast cancer, Colorectal cancer, Prostate cancer, Stomach cancer, Other cancer type), By Application (Diagnostics, Drug discovery and development, Prognostics, Risk assessment, Other application), and By Geography.
This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects of this comprehensive market, by assessing major geographies, and is a valuable asset for the existing players, new entrants, and future investors. The study presents a detailed market analysis, with inputs derived from industry professionals across the value chain.
 
Global Cancer Biomarker Market scenario
 
The adoption of western lifestyles in developing regions, growing prevalence on research of cancer biomarkers, the improved precision and speed of diagnosis, high investment through government and private funds in cancer related research, development of highly specific drugs, the growth in importance of biological and targeted drug therapies, technological advancements, and the growing use of personalized medicine and companion diagnostics are primarily driving the growth of the Global Cancer Biomarker market.
The Global Cancer Biomarker Market report provides data tables and includes charts and graphs for visual analysis.
Request Free Sample Report for Global Cancer Biomarker Market by profiling, biomarker, cancer type, application, and Geography:  https://www.inkwoodresearch.com/reports/cancer-biomarker-market/#request-free-sample
 
Market Segmentation
On the basis of Profiling, Global Cancer Biomarker market is segmented into:
  • Omic Technology
  • Imaging Technologies
  • Immunoassays
  • Cytogenetic-Based Tests
On the basis of Biomarker, Global Cancer Biomarker market is segmented into:
  • Genetic Biomarkers
  • Protein Biomarkers
  • Glyco Biomarkers
On the basis of Cancer Type, Global Cancer Biomarker market is segmented into:
  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Stomach Cancer
  • Others Cancer Type
On the basis of Application, Global Cancer Biomarker market is segmented into:
  • Diagnostics
  • Drug Discovery and Development
  • Prognostics
  • Risk Assessment
  • Other Application
 
Report Highlights
- The report provides a detailed analysis of the current and future market trends, to identify the investment opportunities
- Market forecasts till 2027, using estimated market values as the base numbers
- Key market trends across the business segments, regions and countries
- Key developments and strategies observed in the market
- Market dynamics such as drivers, restraints, opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2027

Companies Profiled
  • ABBOTT LABORATORIES
  • AGENDIA N.V.
  • AGILENT TECHNOLOGIES, INC.
  • AUREON BIOSCIENCES, INC
  • ASTELLAS PHARMA INC.
  • BECKMAN COULTER
  • BECTON DICKINSON AND COMPANY
  • BRISTOL-MYERS SQUIBB
  • CELGENE CORPORATION
  • CLARIENT, INC. (ACQUIRED BY NEOGENOMICS LABORATORIES)
  • DIADEXUS INC. (ACQUIRED BY DIAZYME LABORATORIES)
  • ILLUMINA, INC.
  • ROCHE DIAGNOSTICS LTD
  • SANOFI
  • QIAGEN N.V.
 
 
Related Reports
 
Global 3D Medical Imaging market - Global 3D Medical Imaging market is likely to grow with an anticipated CAGR of 9.03% over the forecast period of 2018-2026.
Global Biopsy Devices market - Global Biopsy Devices market is predicted to exhibit a CAGR of 6.16% by revenue during the forecast years 2018-2026.
Global Breast Imaging market – The Global Breast Imaging market is predicted to exhibit a CAGR of 7.81% during the forecast years 2019-2027.
 

Other Industry News

Ready to start publishing

Sign Up today!